Clinical Trial Update: Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H) [NA]

View source ↗

Summary

A clinical trial update notes that a study evaluating dutasteride after failure of finasteride for symptomatic benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Avodart (dutasteride)
• PROSCAR (FINASTERIDE)

Snippet

Sponsor: North Florida/South Georgia Veterans Health System | Conditions: Benign Prostatic Hypertrophy | NA | Status: COMPLETED